Latest filing published 14 Nov 2023 for Tabula Rasa HealthCare, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kathrine O'Brien is a declared insider at 2 companies (board member); the most frequent names are Tabula Rasa HealthCare, Inc. and AMAG Pharmaceuticals Inc. The record holds 14 filings, for trades running from 2 November 2018 to 3 November 2023.
On the market, this insider has only ever bought: 1 purchase, €89k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 11 share grants.
Most recently, on 14 November 2023, the filings show a transaction in Tabula Rasa HealthCare, Inc. The last purchase on record was published on 12 November 2021, which is 1,804 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations